HIGH

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Quick Facts at a Glance

Recall Date
March 20, 2026
Hazard Level
HIGH
Brand
Fagron Compounding Services
Geographic Scope
1 states

Hazard Information

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Fagron Compounding Services recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02. Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port. Classification: Class II. Quantity: 25,260 bags. Distribution: Nationwide in the U.S.A.

View Original Recall on FDA - Drug Safety

Browse More Recalls

More from FDA_DRUGHealth & Personal CareDrugs & Medications

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot: C274-000049934
Exp.: 4/23/2026
C274-000049963
Exp.:4/24/2026
C274-000050074
+15 more
Affected States
ALL
Report Date
April 15, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

K.C. Pharmaceuticals Recalls 8 OTC Eye Drops for Sterility Concerns (2026)

K.C. Pharmaceuticals recalled eight OTC eye drops sold nationwide under CVS Health, Walgreens and Kroger brands after sterility could not be verified. The recall covers all lots within expiry through Oct 31, 2026. Nonsterile eye drops can harbor bacteria and fungus, causing serious infections that may lead to vision loss. Stop using recalled products and return them for a full refund at the store.

K.C. Pharmaceuticals
Nonsterile eye
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 1mg 100-Count Capsules Recalled for Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.

Biocon Pharma
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 5mg Recall 28,157 Bottles Over Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 28,157 bottles of PRAZOSIN HYDROCHLORIDE capsules, distributed nationwide in the USA. The recall cites cGMP deviation due to detection of N-nitroso-prazosin impurity C above acceptable limits. Stop using the product immediately and contact Appco Pharma LLC or your healthcare provider for guidance.

Prazosin Hydrochloride
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Prazosin Hydrochloride 2 mg Capsules Recalled for Nitrosamine Impurity (58,896 bottles, 2026)

Biocon Pharma Inc. recalled 58,896 bottles of Prazosin Hydrochloride Capsules, USP, 2 mg, 100-count bottle. The product was distributed nationwide in the USA and manufactured by Appco Pharma LLC. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or their health‑

Prazosin Hydrochloride
cGMP deviation:
Read more